Literature DB >> 27527715

The Association of Surgical Margins and Local Recurrence in Women with Ductal Carcinoma In Situ Treated with Breast-Conserving Therapy: A Meta-Analysis.

M Luke Marinovich1, Lamiae Azizi2, Petra Macaskill2, Les Irwig2, Monica Morrow3, Lawrence J Solin4, Nehmat Houssami2.   

Abstract

PURPOSE: There is no consensus on adequate negative margins in breast-conserving surgery (BCS) for ductal carcinoma in situ (DCIS). We systematically reviewed the evidence on margins in BCS for DCIS.
METHODS: A study-level meta-analysis of local recurrence (LR), microscopic margin status and threshold distance for negative margins. LR proportion was modeled using random-effects logistic meta-regression (frequentist) and network meta-analysis (Bayesian) that allows for multiple margin distances per study, adjusting for follow-up time.
RESULTS: Based on 20 studies (LR: 865 of 7883), odds of LR were associated with margin status [logistic: odds ratio (OR) 0.53 for negative vs. positive/close (p < 0.001); network: OR 0.45 for negative vs. positive]. In logistic meta-regression, relative to >0 or 1 mm, ORs for 2 mm (0.51), 3 or 5 mm (0.42) and 10 mm (0.60) showed comparable significant reductions in the odds of LR. In the network analysis, ORs relative to positive margins for 2 (0.32), 3 (0.30) and 10 mm (0.32) showed similar reductions in the odds of LR that were greater than for >0 or 1 mm (0.45). There was weak evidence of lower odds at 2 mm compared with >0 or 1 mm [relative OR (ROR) 0.72, 95 % credible interval (CrI) 0.47-1.08], and no evidence of a difference between 2 and 10 mm (ROR 0.99, 95 % CrI 0.61-1.64). Adjustment for covariates, and analyses based only on studies using whole-breast radiotherapy, did not change the findings.
CONCLUSION: Negative margins in BCS for DCIS reduce the odds of LR; however, minimum margin distances above 2 mm are not significantly associated with further reduced odds of LR in women receiving radiation.

Entities:  

Mesh:

Year:  2016        PMID: 27527715      PMCID: PMC5160992          DOI: 10.1245/s10434-016-5446-2

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  47 in total

1.  Young age is not associated with increased local recurrence for DCIS treated by breast-conserving surgery and radiation.

Authors:  Aruna Turaka; Gary M Freedman; Tianyu Li; Penny R Anderson; Ramona Swaby; Nicos Nicolaou; Lori Goldstein; Elin R Sigurdson; Richard J Bleicher
Journal:  J Surg Oncol       Date:  2009-07-01       Impact factor: 3.454

2.  Five-year analysis of treatment efficacy and cosmesis by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation.

Authors:  Frank Vicini; Peter Beitsch; Coral Quiet; Mark Gittleman; Vic Zannis; Ricky Fine; Pat Whitworth; Henry Kuerer; Bruce Haffty; Martin Keisch; Maureen Lyden
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-05-14       Impact factor: 7.038

3.  Excision alone for small size ductal carcinoma in situ of the breast.

Authors:  Haeyoung Kim; Jae Myoung Noh; Doo Ho Choi; Jihye Lee; Seok Jin Nam; Jeong Eon Lee; Won Park; Seung Jae Huh
Journal:  Breast       Date:  2014-06-23       Impact factor: 4.380

4.  Ductal carcinoma in situ of the breast results of conservative and radical treatments in 716 patients.

Authors:  B Cutuli; C Cohen-Solal-Le Nir; B De Lafontan; H Mignotte; V Fichet; R Fay; V Servent; S Giard; C Charra-Brunaud; H Auvray; F Penault-Llorca; J C Charpentier
Journal:  Eur J Cancer       Date:  2001-12       Impact factor: 9.162

5.  Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history.

Authors:  H Hiramatsu; B A Bornstein; A Recht; S J Schnitt; J K Baum; J L Connolly; R B Duda; A J Guidi; C M Kaelin; E B Silver; J R Harris
Journal:  Cancer J Sci Am       Date:  1995 May-Jun

6.  Mammographically detected ductal carcinoma in situ treated with conservative surgery with or without radiation therapy: patterns of failure and 10-year results.

Authors:  L L Kestin; N S Goldstein; A A Martinez; M Rebner; M Balasubramaniam; R C Frazier; J T Register; J Pettinga; F A Vicini
Journal:  Ann Surg       Date:  2000-02       Impact factor: 12.969

7.  Role of radiotherapy boost in women with ductal carcinoma in situ: a single-center experience in a series of 389 patients.

Authors:  I Meattini; L Livi; D Franceschini; C Saieva; F Meacci; L Marrazzo; B Bendinelli; V Scotti; C De Luca Cardillo; J Nori; L Sanchez; L Orzalesi; P Bonomo; D Greto; M Bucciolini; S Bianchi; G Biti
Journal:  Eur J Surg Oncol       Date:  2013-03-20       Impact factor: 4.424

8.  Intraductal breast cancer: review of 183 consecutive cases.

Authors:  L Cataliotti; V Distante; S Ciatto; S Bianchi; P Pacini; R Simoncini; M Rosselli Del Turco; G Cardona; F Falli
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

Review 9.  Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.

Authors:  Beth A Virnig; Todd M Tuttle; Tatyana Shamliyan; Robert L Kane
Journal:  J Natl Cancer Inst       Date:  2010-01-13       Impact factor: 13.506

10.  Treatment for ductal carcinoma in situ in an Asian population: outcome and prognostic factors.

Authors:  Esther W L Chuwa; Vincent H S Tan; Puay-Hoon Tan; Wei-Sean Yong; Guy-Hui Ho; Chow-Yin Wong
Journal:  ANZ J Surg       Date:  2008 Jan-Feb       Impact factor: 1.872

View more
  38 in total

1.  The Value of Repeated Breast Surgery as a Quality Indicator in Breast Cancer Care.

Authors:  Francesca Tamburelli; Riccardo Ponzone
Journal:  Ann Surg Oncol       Date:  2020-06-10       Impact factor: 5.344

2.  [Optimal margins for breast-conserving surgery with whole-breast irradiation in ductal carcinoma in situ : Results of the ASTRO, ASCO, and SSO consensus guideline].

Authors:  Rainer Souchon
Journal:  Strahlenther Onkol       Date:  2017-10       Impact factor: 3.621

Review 3.  Trends and controversies in multidisciplinary care of the patient with breast cancer.

Authors:  Laura S Dominici; Monica Morrow; Elizabeth Mittendorf; Jennifer Bellon; Tari A King
Journal:  Curr Probl Surg       Date:  2016-11-29       Impact factor: 1.909

Review 4.  Update of the American Society of Breast Surgeons Toolbox to address the lumpectomy reoperation epidemic.

Authors:  Maureen P McEvoy; Jeffrey Landercasper; Himani R Naik; Sheldon Feldman
Journal:  Gland Surg       Date:  2018-12

5.  Impact of Age on Locoregional and Distant Recurrence After Mastectomy for Ductal Carcinoma In Situ With or Without Microinvasion.

Authors:  Anita Mamtani; Faina Nakhlis; Stephanie Downs-Canner; Emily C Zabor; Monica Morrow; Tari A King; Kimberly J Van Zee
Journal:  Ann Surg Oncol       Date:  2019-08-22       Impact factor: 5.344

6.  [Update of the German S3 breast cancer guideline : What is new for pathologists?]

Authors:  A Lebeau; C Denkert; P Sinn; M Schmidt; A Wöckel
Journal:  Pathologe       Date:  2019-03       Impact factor: 1.011

7.  Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma in Situ.

Authors:  Monica Morrow; Kimberly J Van Zee; Lawrence J Solin; Nehmat Houssami; Mariana Chavez-MacGregor; Jay R Harris; Janet Horton; Shelley Hwang; Peggy L Johnson; M Luke Marinovich; Stuart J Schnitt; Irene Wapnir; Meena S Moran
Journal:  Pract Radiat Oncol       Date:  2016-06-24

8.  Ductal Carcinoma In Situ and Margins <2 mm: Contemporary Outcomes With Breast Conservation.

Authors:  Audree B Tadros; Benjamin D Smith; Yu Shen; Heather Lin; Savitri Krishnamurthy; Anthony Lucci; Carlos H Barcenas; Rosa F Hwang; Gaiane Rauch; Lumarie Santiago; Eric A Strom; Sarah M DeSnyder; Wei T Yang; Dalliah M Black; Constance T Albarracin; Mariana Chavez-MacGregor; Kelly K Hunt; Henry M Kuerer
Journal:  Ann Surg       Date:  2019-01       Impact factor: 12.969

9.  Does margin width impact breast cancer recurrence rates in women with breast conserving surgery for ductal carcinoma in situ?

Authors:  Devon Livingston-Rosanoff; Amy Trentham-Dietz; John M Hampton; Polly A Newcomb; Lee G Wilke
Journal:  Breast Cancer Res Treat       Date:  2021-06-15       Impact factor: 4.872

Review 10.  Margins in breast cancer: How much is enough?

Authors:  Melissa Pilewskie; Monica Morrow
Journal:  Cancer       Date:  2018-01-16       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.